A new tool to screen drugs targeting E. coli

MechGate measures how small molecules pass through membranes and escape pumps to find antibacterial activity.

Researchers introduced MechGate to screen small molecule drugs targeting Escherichia coli. This tool evaluates molecules against permeation, efflux, and antibacterial activity.

The tool uses SMILES input to report five different measures. Two measures track permeation via porins. One measure tracks permeation via the phospholipid membrane. One measure tracks efflux and one tracks activity.

Permeation is the process of crossing the cell membrane. Efflux refers to the action of efflux pumps. Antibacterial activity is the ability of a molecule to hit its targets.

Existing evaluations do not separate the steps of crossing the membrane and escaping pumps. MechGate allows a molecule that fails to be traced to the specific step that stops it.

On an external set of marketed antibacterials, the measures give a precision of 0.7890.789 to 0.8730.873. Combining the measures as the mechanism predicts raises precision to 0.920.92.

The code is open-source and does not require commercial software. All features come from papers that state their mechanism.

Key facts

  • MechGate reports five measures for permeation, efflux, and activity.
  • The tool achieved a precision of 0.920.92 when combining measures as the mechanism predicts.
  • The tool can trace which specific step stops a molecule from working.

All sections

Edition